20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cardiovascular diseases (CVDs) have become a serious threat to human life and health. Though many drugs acting via different mechanism of action are available in the market as conventional formulations for the treatment of CVDs, they are still far from satisfactory due to poor water solubility, low biological efficacy, non-targeting, and drug resistance. Nano-drug delivery systems (NDDSs) provide a new drug delivery method for the treatment of CVDs with the development of nanotechnology, demonstrating great advantages in solving the above problems. Nevertheless, there are some problems about NDDSs need to be addressed, such as cytotoxicity. In this review, the types and targeting strategies of NDDSs were summarized, and the new research progress in the diagnosis and therapy of CVDs in recent years was reviewed. Future prospective for nano-carriers in drug delivery for CVDs includes gene therapy, in order to provide more ideas for the improvement of cardiovascular drugs. In addition, its safety was also discussed in the review.

          Related collections

          Most cited references152

          • Record: found
          • Abstract: found
          • Article: not found

          Tumor delivery of macromolecular drugs based on the EPR effect.

          Enhanced permeability and retention (EPR) effect is the physiology-based principal mechanism of tumor accumulation of large molecules and small particles. This specific issue of Advanced Drug Delivery Reviews is summing up multiple data on the EPR effect-based drug design and clinical outcome. In this commentary, the role of the EPR effect in the intratumoral delivery of protein and peptide drugs, macromolecular drugs and drug-loaded long-circulating pharmaceutical nanocarriers is briefly discussed together with some additional opportunities for drug delivery arising from the initial EPR effect-mediated accumulation of drug-containing macromolecular systems in tumors. Copyright © 2010 Elsevier B.V. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Atherosclerosis. the road ahead.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Design of polymeric nanoparticles for biomedical delivery applications.

              Polymeric nanoparticles-based therapeutics show great promise in the treatment of a wide range of diseases, due to the flexibility in which their structures can be modified, with intricate definition over their compositions, structures and properties. Advances in polymerization chemistries and the application of reactive, efficient and orthogonal chemical modification reactions have enabled the engineering of multifunctional polymeric nanoparticles with precise control over the architectures of the individual polymer components, to direct their assembly and subsequent transformations into nanoparticles of selective overall shapes, sizes, internal morphologies, external surface charges and functionalizations. In addition, incorporation of certain functionalities can modulate the responsiveness of these nanostructures to specific stimuli through the use of remote activation. Furthermore, they can be equipped with smart components to allow their delivery beyond certain biological barriers, such as skin, mucus, blood, extracellular matrix, cellular and subcellular organelles. This tutorial review highlights the importance of well-defined chemistries, with detailed ties to specific biological hurdles and opportunities, in the design of nanostructures for various biomedical delivery applications.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Bioeng Biotechnol
                Front Bioeng Biotechnol
                Front. Bioeng. Biotechnol.
                Frontiers in Bioengineering and Biotechnology
                Frontiers Media S.A.
                2296-4185
                31 January 2020
                2019
                : 7
                : 489
                Affiliations
                [1] 1The Eighth Affiliated Hospital, Sun Yat-sen University , Shenzhen, China
                [2] 2Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Nutrition and Food Hygiene, School of Public Health, Southern Medical University , Guangzhou, China
                Author notes

                Edited by: Wenguo Cui, School of Medicine, Shanghai Jiao Tong University, China

                Reviewed by: Jian Zhong, Shanghai Ocean University, China; Zhilu Yang, Southwest Jiaotong University, China

                *Correspondence: Wenzhen Liao wenzhenliao@ 123456163.com

                This article was submitted to Nanobiotechnology, a section of the journal Frontiers in Bioengineering and Biotechnology

                †These authors have contributed equally to this work

                Article
                10.3389/fbioe.2019.00489
                7005934
                32083068
                deb4538c-c2ad-453e-89b3-6eaf852c0059
                Copyright © 2020 Deng, Zhang, Shen, He, Wu, Liao and Yuan.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 21 November 2019
                : 31 December 2019
                Page count
                Figures: 5, Tables: 7, Equations: 0, References: 171, Pages: 18, Words: 13757
                Funding
                Funded by: National Natural Science Foundation of China 10.13039/501100001809
                Award ID: 81972488
                Award ID: 81701836
                Award ID: 81973013
                Award ID: 8197120078
                Funded by: Science and Technology Planning Project of Guangdong Province 10.13039/501100012245
                Award ID: 2019B020210002
                Funded by: Natural Science Foundation of Guangdong Province 10.13039/501100003453
                Award ID: C1051164
                Categories
                Bioengineering and Biotechnology
                Review

                nano-drug delivery system,cardiovascular disease,targeting strategy,application progress,safety

                Comments

                Comment on this article